Table 2.
LncRNA | Expression | Location | Action | Targeted Pathway | Downstream Targets | References |
---|---|---|---|---|---|---|
ANRIL | Down | plasma of AECOPD patients | Anti-inflammatory | – | TNF, IL1B, IL17A, CXCL8 | [12] |
CCAT1 | Up | lungs of COPD patients and CSE-treated HBE cells | MircoRNA sponging and epigenetic modification | miR-152-3p | – | [13] |
GAS5 | Up | Human lung fibroblast cell line | Involved in the regulation of pyroptosis | miR-223-3p | NLRP3 | [15] |
Down | lung of mice exposed to CS | Suppress airway inflammation and fibroblast activation | miR-217-5p | PTEN | [64] | |
H19 | Up | quadriceps of FFMI patients with COPD | Susceptibility to low FFMI | – | MYOD1 | [65,66] |
HOTAIR | Up | lungs of COPD patients and CSE-treated HPVEC | aggravate the apoptosis of CSE HPVEC | – | DNMT1 | [67] |
Up | male BALB/c mice exposed to CS and CSE-treated HBE cells | – | – | IL6, CXCL8, CDH2, VIM, ACTA2, CDH1 | [68] | |
IL7R | Down | serum from COPD patients |
Protected against cellular senescence and apoptosis | – | EZH2 recruitment | [52,59,69] |
LASI | Up | CS-exposed macaques and airways of COPD smokers | Increase the mucoinflammatory response | – | secretory mucin MUC5AC. and inflammatory factors, ICAM-1, and IL-6 |
[56,70] |
LUCAT1 | Up | serum from COPD patients |
Promoted CSE-induced 16HBE cells apoptosis and inhibited proliferation | miR- 181a- 5p | Wnt/β-catenin | [71,72] |
MEG3 | Up | lungs of COPD patients and CSE-treated HBE cells | Induces apoptosis and inflammation | Apoptosis | IL1B, IL6, TNF | [73] |
MHC-R | Up | lungs of rats exposed to air pollution PM | Regulate the immune activities of DCs | – | GATA3 | [74] |
MIAT | Up | lung of mice exposed to CS | Knockdown of MIAT attenuates CS-induced airway remodeling | miR-29c-3p | HIF3A | [53] |
TUG1 | Up | lungs and sputum from smokers and non-smokers with COPD | Inhibits inflammation and airway remodeling | – | DUSP6 | [75] |
TGFB1 treated BEAS-2B and HFL1 cells | Inhibits cell proliferation | – | ACTA2, FN1 | [14] | ||
SNHG5 | Down | COPD tissues and CSE-treated HBE cells | Repress cell apoptosis, proliferation, and inflammation | miR-132 | PTEN | [76] |
LINC00612 | Down | COPD tissues and CSE-treated HBE cells | Repress cell apoptosis, inflammation, and oxidative stress | miR-31-5p | Notch1 | [48] |
HOXA-AS2 | Down | COPD tissues and CSE-treated HBE cells | Repress cell apoptosis | – | Notch1 | [60] |
MIR155HG | Up | Lung tissues of smokers without or with COPD | Contributed to the apoptosis and inflammation | miR-128-5p | BRD4 | [54] |
Nqo1-AS1 | Up | The cytoplasm of mouse alveolar epithelium | Attenuated CS-induced oxidative stress | – | Nqo1 | [50] |
LINC00987 | Up | COPD tissues | Repress cell apoptosis, inflammation, and oxidative stress | let-7b-5p | SIRT1 | [51] |
PVT1 | Up | peripheral blood mononuclear cells (PBMCs), and serum of COPD patients | – | miR-146a | – | [77] |
RP11-86H7.1 | Up | TRAPM2.5 exposed HBE cells | – | miR-9-5p | NFKB1/NF-κB | [47] |
NEAT1 | Up | plasma of COPD patients | – | miR-193a | – | [78] |